Clinic
Geisinger Wyoming Valley Medical Center
Geisinger Wyoming Valley Medical Center was paid $295K by Medicaid between Jan 2020 and Dec 2024, across 31 billing codes. Its largest line is 0202U, Oncology (prostate), multianalyte, gene expression profiling — 39% of everything it billed.
33Billing provider infoGEISINGER WYOMING VALLEY MEDICAL CENTER
DALLAS, PA 18612
DALLAS, PA 18612
33aNPI1649568403assigned 07/14/2011
33bProvider typeClinic/Center
28Total paid$295K
24GClaims9,781
24DCodes billed31
24AFirst – last monthJan 2020 – Dec 2024
Compared with peers
Next to other Clinic/Center providers in Pennsylvania
Rank by total paid#96 of 176
Median peer was paid$441K
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MULL, CINDY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 586 | $12K | |
| 2021 | 6,283 | $120K | |
| 2022 | 721 | $26K | |
| 2023 | 1,257 | $82K | |
| 2024incomplete | 934 | $54K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 39% | 443 | 418 | $114K |
| 87631 | 16% | 345 | 331 | $48K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 10% | 362 | 352 | $30K |
| 80053 | Comprehensive metabolic panel | 5.6% | 1,488 | 1,445 | $17K |
| 84443 | Thyroid stimulating hormone (TSH) | 5.5% | 738 | 726 | $16K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 5.1% | 124 | 112 | $15K |
| 80061 | Lipid panel | 3.1% | 693 | 687 | $9K |
| 0100U | 2.6% | 17 | 17 | $8K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.7% | 342 | 332 | $5K |
| 87430 | 1.6% | 787 | 758 | $5K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 833 | 796 | $5K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.4% | 111 | 107 | $4K |
19 more codes
| 36415 | Collection of venous blood by venipuncture | 1.1% | 1,803 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 442 | $3K |
| 85027 | <1% | 384 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 118 | $3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 25 | $2K |
| 82607 | <1% | 104 | $1K | |
| 84439 | <1% | 157 | $1K | |
| 83540 | <1% | 77 | $590.20 | |
| 82728 | <1% | 51 | $580.38 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 69 | $534.66 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 50 | $469.02 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $318.91 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $318.91 |
| 83550 | <1% | 53 | $247.15 | |
| 83655 | <1% | 14 | $225.56 | |
| 86140 | <1% | 51 | $161.14 | |
| 85652 | <1% | 48 | $152.22 | |
| 82043 | <1% | 12 | $87.00 | |
| 82570 | <1% | 12 | $75.75 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMULL, CINDY (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Geisinger Clinic | Danville, PA | $74.54M |
| Community Medical Center | Scranton, PA | $22.62M |
| Geisinger Clinic | Danville, PA | $14.93M |
| West Shore Advanced Life Support Services, INC. | Danville, PA | $4.41M |
| Geisinger Clinic | Pottsville, PA | $3.39M |
| Geisinger Clinic | Lewistown, PA | $2.93M |
| Geisinger Clinic | Scranton, PA | $2.63M |
| Geisinger Clinic | Wilkes Barre, PA | $2.35M |
| Geisinger Clinic | Danville, PA | $2.28M |
| Geisinger Jersey Shore Hospital | Jersey Shore, PA | $2.17M |
| Geisinger Clinic | Scranton, PA | $1.71M |
| Geisinger Clinic | Tunkhannock, PA | $1.11M |
| Geisinger Clinic | Orwigsburg, PA | $974K |
| Geisinger Clinic | Pittston, PA | $942K |
| Geisinger Clinic | Berwick, PA | $896K |
| Geisinger Clinic Selinsgrove | Selinsgrove, PA | $819K |
| Geisinger Clinic | Philipsburg, PA | $678K |
| Geisinger Clinic | Lewisburg, PA | $557K |
| Geisinger Clinic | Mountain Top, PA | $523K |
| Geisinger Clinic | Kulpmont, PA | $489K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.